Results 71 to 80 of about 499,140 (140)

Transcatheter Aortic Valve Durability: Focus on Structural Valve Deterioration

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Transcatheter aortic valve replacement has emerged as a valuable alternative to surgical aortic valve replacement in patients with severe aortic stenosis. Given the expansion of transcatheter aortic valve replacement to lower‐risk and younger populations
Antonin Trimaille, Adrien Carmona, Sandy Hmadeh, Dinh Phi Truong, Benjamin Marchandot, Shinnosuke Kikuchi, Kensuke Matsushita, Patrick Ohlmann, Valérie Schini‐Kerth, Josep Rodés‐Cabau, Philippe Pibarot, Olivier Morel   +11 more
doaj   +1 more source

Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older

Journal of the American Geriatrics Society, EarlyView.
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet, Mélissa Sabin, Thierry Le Tourneau, Thibaut Manigold, Anne‐Sophie Boureau   +4 more
wiley   +1 more source

Transapical valve-in-valve implantation for regurgitant stented aortic bioprostheses

, 2012
Transcatheter aortic valve implantation (TAVI) is rapidly evolving as an alternative treatment option for elderly patients with severe symptomatic aortic stenosis and excessive risk for surgical intervention.
Windecker, Stephan, Carrel, Thierry, Pilgrim, Thomas, Wenaweser, Peter, Kadner, Alexander, Stortecky, Stefan   +5 more
core   +1 more source

Bicuspid Aortic Valve Disease: Classifications, Treatments, and Emerging Transcatheter Paradigms

Structural Heart
Bicuspid aortic valve (BAV) is a common congenital valvular malformation, which may lead to early aortic valve disease and bicuspid-associated aortopathy. A novel BAV classification system was recently proposed to coincide with transcatheter aortic valve
Ankur Kalra, MD, Rajiv Das, MB ChB, MD, Mohammad Alkhalil, MD, DPhil, Iryna Dykun, MD, Alessandro Candreva, MD, Omar Jarral, MBBS, PhD, Syed M. Rehman, MBBS, Monil Majmundar, MD, Kunal N. Patel, MD, MPH, Josep Rodes-Cabau, MD, PhD, Michael J. Reardon, MD, Rishi Puri, MBBS, PhD   +11 more
doaj   +1 more source

Leadless Pacemaker Implantation in High‐Risk Patients: Real‐World Outcomes From a Multicenter Israeli Registry

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz, Marianna Vander, David Luria, Moshe Rav Acha, Yoav Michowitz, Alon Barsheshet, Gregory Golovchiner, Roy Beinart   +7 more
wiley   +1 more source

48. TAVI – From nursing perspective

Journal of the Saudi Heart Association, 2015
Aortic stenosis is a common valvular pathological finding in older adults. Currently, aortic valve replacement is the gold-standard treatment for severe symptomatic aortic stenosis.
Aljuhara AlMarzoog
doaj   +1 more source

A Reassessment of Prophylactic Antibiotics in Low‐Infection‐Risk Electrophysiology Procedures

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Certain electrophysiology (EP) procedures are associated with minimal tissue disruption and do not involve permanent transvenous leads. As a result, these interventions carry a lower risk of device‐ or procedure‐related infection. These procedures include placement of implantable cardiac monitors, leadless pacemakers, and left atrial appendage
Rahel M. Sileshi, Katherine Mathes, Sathya Kosuri, Amulya Gupta, Neil Phillips, Rhea Pimentel, Martin Emert, Siva Soma, Rigoberto Ramirez, Raghuveer Dendi, Madhu Reddy, Seth H. Sheldon, Wissam El Atrouni, Larry M. Baddour, Amit Noheria   +14 more
wiley   +1 more source

Transcatheter aortic valve replacement

Research Reports in Clinical Cardiology, 2013
Anneke Damberg, Carina Benstoem, Ruediger Autschbach, Andreas GoetzenichDepartment of Cardiovascular and Thoracic Surgery, University Clinic RWTH Aachen, Aachen, GermanyAbstract: The standard treatment for symptomatic severe aortic valve stenosis is ...
Damberg A, Benstoem C, Autschbach R, Goetzenich A   +3 more
doaj  

Transcatheter aortic valve in transcatheter aortic valve: Clinical characteristics and outcomes

Annals, Academy of Medicine, Singapore
Transcatheter aortic valve implantation (TAVI) is an efficacious treatment for aortic stenosis (AS).1,2 With more TAVI performed in younger patients, concerns about durability/treatment once index prostheses degenerate arose.3 We examined data to ...
Hai Yang Fang, See Hooi Ewd, Mohammed Rizwan Amanullah, Zameer Abdul Aziz, Sivaraj Pillai Govindasamy, Victor Tar Toong Chao, Jonathan Jiunn-Liang Yap, Kay Woon Ho   +7 more
doaj   +1 more source

Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]

, 2017
BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller, Maisano, Francesco, Roffi, Marco, Anna Franzone, Jürg Grünenfelder, Peter Wenaweser, Christoph Huber, Haynes, Alan G, Alan G. Haynes, Huber, Christoph, Noble, Stéphane Laurent, Enrico Ferrari, Toggweiler, Stefan, Stefan Stortecky, Fabian Nietlispach, Windecker, Stephan, Noble, Stephane, Thomas Pilgrim, Ferrari, Enrico, Marco Roffi, Stéphane Noble, Wenaweser, Peter, Stortecky, Stefan, Nietlispach, Fabian, Franzone, Anna, Stephan Windecker, Jeger, Raban, Stefan Toggweiler, Pilgrim, Thomas, David Tueller, Francesco Maisano, Müller, Oliver, Tueller, David, Raban Jeger, Grünenfelder, Jürg, Tueller, D., Muller O, Stortecky, S., Noble, S., Windecker S, Wenaweser P, Toggweiler S, Roffi, M., Maisano, F., Huber C, Muller, O., Noble S, Grünenfelder, J., Roffi M, Stortecky S, Pilgrim, T., Jeger R, Haynes, A.G., Tueller D, Ferrari E, Jeger, R., Windecker, S., Nietlispach F, Wenaweser, P., Grünenfelder J, Franzone, A., Nietlispach, F., Franzone A, Pilgrim T, Toggweiler, S., Haynes, Alan G., Ferrari, E., Haynes AG, Maisano F, Huber, C.   +69 more
core   +4 more sources